LegoChem Biosciences (Korea) Investor Sentiment

141080 Stock  KRW 95,500  3,900  3.92%   
About 62% of LegoChem Biosciences' investor base is looking to short. The analysis of current outlook of investing in LegoChem Biosciences suggests that many traders are alarmed regarding LegoChem Biosciences' prospects. The current market sentiment, together with LegoChem Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use LegoChem Biosciences stock news signals to limit their universe of possible portfolio assets.
  
over six months ago at news.google.com         
LegoChem Biosciences Enters into Research Licensing Agreement with Takeda Pharmaceuticals Company Li...
Google News at Macroaxis
over six months ago at news.google.com         
Despite currently being unprofitable, LegoChem Biosciences has delivered a 92 percent return to shar...
Google News at Macroaxis
over six months ago at news.google.com         
Orion completes acquisition of LegoChem Biosciences -
Google News at Macroaxis
over six months ago at news.google.com         
Snack maker Orion emerges as LigaChem Bios largest shareholder - KBR
Google News at Macroaxis
over six months ago at news.google.com         
Samsung Biologics Partners with LegoChem Biosciences on ADCs - Pharmaceutical Technology Magazine
Google News at Macroaxis
over six months ago at news.google.com         
Samsung Biologics Partners with LegoChem Biosciences - European Pharmaceutical Manufacturer
Google News at Macroaxis
over six months ago at news.google.com         
Samsung Biologics Collaborates with LegoChem Biosciences on ADC Therapeutic Development - BusinessKo...
Google News at Macroaxis
over six months ago at news.google.com         
Minute to Read Samsung Galaxy S24 ushers in new era of mobile AI -
Google News at Macroaxis
over six months ago at news.google.com         
Orion Breaks into Biotech Industry by Taking Over LegoChem Bio - BusinessKorea
Google News at Macroaxis
over six months ago at news.google.com         
Korean confectionary giant Orion to acquire biggest stake in Legochem - BioWorld Online
Google News at Macroaxis
over six months ago at news.google.com         
Orion Unit Pan Orion Corp Ltd To Acquire 548.5 Billion Won Worth Of Shares In Legochem Biosciences I...
Google News at Macroaxis
over six months ago at news.google.com         
Stock Watch The Deal Flow Before Christmas - Scrip
Google News at Macroaxis
over six months ago at news.google.com         
LegoChem Biosciences, Inc.s Equity Buyback announced on June 28, 2023, has expired with 140000 share...
Google News at Macroaxis
over six months ago at news.google.com         
LegoChem licenses cancer treatment to JJ in historic 1.7 billion deal - The Korea JoongAng Daily
Google News at Macroaxis
over a year ago at news.google.com         
Legochem Biosciences divulges new TLR7 and TLR8 agonists - BioWorld Online
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about LegoChem Biosciences that are available to investors today. That information is available publicly through LegoChem media outlets and privately through word of mouth or via LegoChem internal channels. However, regardless of the origin, that massive amount of LegoChem data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of LegoChem Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of LegoChem Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to LegoChem Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive LegoChem Biosciences alpha.

LegoChem Biosciences Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for LegoChem Stock analysis

When running LegoChem Biosciences' price analysis, check to measure LegoChem Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LegoChem Biosciences is operating at the current time. Most of LegoChem Biosciences' value examination focuses on studying past and present price action to predict the probability of LegoChem Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LegoChem Biosciences' price. Additionally, you may evaluate how the addition of LegoChem Biosciences to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals